Terms: = Leukemia AND IGK AND Treatment
15 results:
1. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
[TBL] [Abstract] [Full Text] [Related]
2. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
[TBL] [Abstract] [Full Text] [Related]
3. CAR T cells targeting options in the fight against multiple myeloma.
Nicolini F; Bravaccini S; Mazza M; Gruszka AM; Tazzari M; MartÍn-Antonio B; Juan M; Ibrahim T; Maltoni R; Martinelli G; Cerchione C
Panminerva Med; 2021 Mar; 63(1):37-45. PubMed ID: 32955187
[TBL] [Abstract] [Full Text] [Related]
4. Richter's syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review.
Xu L; Song JC; Sun XH; Gao ZF; Lv L; Zhu J
Medicine (Baltimore); 2018 Oct; 97(41):e12701. PubMed ID: 30313065
[TBL] [Abstract] [Full Text] [Related]
5. Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements.
Besbes S; Hamadou WS; Boulland ML; Youssef YB; Achour B; Regaieg H; Khelif A; Fest T; Soua Z
Braz J Med Biol Res; 2017 Jan; 50(1):e5426. PubMed ID: 28099581
[TBL] [Abstract] [Full Text] [Related]
6. Combined IKZF1 and IG markers as new tools for diagnosis and minimal residual disease assessment in Tunisian B-ALL.
Besbes S; Hamadou WS; Boulland ML; Lefranc MP; Ben Youssef Y; Achour B; Khelif A; Fest T; Soua Z
Bull Cancer; 2016 Oct; 103(10):822-828. PubMed ID: 27614734
[TBL] [Abstract] [Full Text] [Related]
7. [Application of Combined Detection of Fusion Gene and BIOMED-2 Standardized Ig Gene Rearrangement System in Childhood B-cell Acute Lymphoblastic leukemia].
Ai XF; Zhang Y; Shi XR; Zheng YC; Zhang L; Wang XJ; Li QH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):352-7. PubMed ID: 27150991
[TBL] [Abstract] [Full Text] [Related]
8. Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.
Logan AC; Vashi N; Faham M; Carlton V; Kong K; Buño I; Zheng J; Moorhead M; Klinger M; Zhang B; Waqar A; Zehnder JL; Miklos DB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1307-13. PubMed ID: 24769317
[TBL] [Abstract] [Full Text] [Related]
9. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
[TBL] [Abstract] [Full Text] [Related]
10. BCL2 and MYC dual-hit lymphoma/leukemia.
Tomita N
J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
[TBL] [Abstract] [Full Text] [Related]
11. Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary igk gene rearrangement, igk deletion, and IGL gene rearrangement.
Klein F; Feldhahn N; Mooster JL; Sprangers M; Hofmann WK; Wernet P; Wartenberg M; Müschen M
J Immunol; 2005 Jan; 174(1):367-75. PubMed ID: 15611260
[TBL] [Abstract] [Full Text] [Related]
12. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract] [Full Text] [Related]
13. Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia.
Bierings M; Szczepański T; van Wering ER; Willemse MJ; Langerak AW; Révész T; van Dongen JJ
Br J Haematol; 2001 Jun; 113(3):757-62. PubMed ID: 11380467
[TBL] [Abstract] [Full Text] [Related]
14. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract] [Full Text] [Related]
15. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
[TBL] [Abstract] [Full Text] [Related]
